Toshiki Etani - Publications

Metastatic Testicular Cancer Complicated by Myelodysplastic Syndrome.

Journal: IJU case reports

Published: April 30, 2026

Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer model.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 26, 2026

Prognostic Impact of Skeletal Muscle Radiodensity in Advanced Urothelial Carcinoma Undergoing Avelumab Maintenance Therapy.

Journal: Cancer diagnosis & prognosis

Published: March 18, 2026

Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a 5-Year Minimum Follow-Up.

Journal: Cancers

Published: March 08, 2026

Intrarenal pressure monitoring in retrograde intrarenal surgery for high-infectious risk populations.

Journal: World journal of urology

Published: February 05, 2026

Clinical characteristics and antimicrobial susceptibility of Aerococcus urinae isolates recovered from urine and blood cultures at a Japanese tertiary care hospital.

Journal: New microbes and new infections

Published: February 02, 2026

Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab.

Journal: Anticancer research

Published: January 23, 2026

Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin.

Journal: Cancer medicine

Published: January 14, 2026

Clinical Characteristics of Providencia rettgeri Bacteraemia and Antimicrobial Susceptibility Patterns.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: January 13, 2026

Establishment of a Patient-Derived Xenograft Model of a Testicular Yolk Sac Tumor.

Journal: Pathology international

Published: December 15, 2025

Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer.

Journal: Japanese journal of clinical oncology

Published: October 28, 2025

A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer.

Journal: Frontiers in immunology

Published: August 07, 2025